LEAPIND vs MARKSANS: Stock Comparison
Head-to-head financial and trading comparison between LEAP India Limited (LEAPIND) and Marksans Pharma Limited (MARKSANS) in the Cross-Sector Peers sector.
LEAPIND
NSE: LEAPINDMARKSANS
NSE: MARKSANSKey Metrics Comparison Table
| Metric | LEAPIND | MARKSANS | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹139.93 | ₹309.10 | — |
| 1-Year Price Return | -3.45% | +74.73% | MARKSANS (78.18% higher) |
| 52-Week High | ₹168.40 | ₹347.60 | — |
| 52-Week Low | ₹134.61 | ₹176.77 | — |
| 30-Day Annualized Volatility | 44.72% | 42.37% | MARKSANS (Steadier) |
| 30-Day Average Daily Volume | 3,241,570 | 2,394,723 | LEAPIND (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between LEAPIND and MARKSANS, which stock gave better returns over the last year?
MARKSANS has outperformed LEAPIND over the past 12 months with a gain of 74.73% compared to -3.45%.
Which stock is less volatile: LEAPIND or MARKSANS?
MARKSANS demonstrated lower price volatility (42.37% annualized) compared to LEAPIND (44.72%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of LEAPIND vs MARKSANS?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are LEAPIND and MARKSANS direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.